Clair Health Commits $1 Million to Fund Women's Health Research

To make up for decades of underfunding in women's health, the first Clair Research Fellowship cohort funds up to 10 early-career researchers across five categories.

• Clair is committing $1 million over the next five years to fund women's health research, a field that receives just 1% of healthcare research funding outside oncology.
• The first cohort funds up to 10 early-career US researchers, each receiving up to $15,000, Clair devices, data access, and conference travel to study areas like perimenopause, sport performance, and hormone-related symptoms.
• Clair invites other women's health and health-tech companies to contribute devices to future cohorts, aiming to expand the fund's reach with each round.

SAN FRANCISCO, Nov. 10, 2026 /PRNewswire/ -- Clair Health today launched the Clair Research Fund, a $1 million commitment to women's health research, deployed across multiple cohorts over the next five years. Its first program, the Clair Research Fellowship, will fund up to 10 early-career researchers in their pursuit of advancing women's health research. Each fellow will receive up to $15,000, Clair devices and research access to Clair data for their study, and travel to present their findings at a scientific conference.

The Research Gap

Women were not required to be in NIH-funded research until 1993. McKinsey found just 1% of healthcare research and innovation goes to female-specific conditions beyond oncology. Women's health research has been underfunded for decades and many of its basic questions still don't have enough data behind them.

• Only 7% of OB-GYNs report feeling prepared by schooling for menopause care.
• PMOS, which affects 1 in 8 women, takes an average of 7 years to diagnose, with 70% of women remaining undiagnosed.

"Clair is on a mission to bridge the data gap in women's health," said Abhinav Agarwal, co-founder and CTO of Clair. "We can't do that alone. The field moves forward when people with different backgrounds and expertise work on it, so we're funding researchers to ask their own questions with Clair."

Clair is the first continuous hormone monitor to collect continuous physiological data. The fund puts this data in the hands of researchers working to close the research gap.

Inside the First Clair Health Research Fund Cohort

Fellows choose their own research questions in five areas: cycle physiology in daily life, perimenopause and menopause, women in sport and training, medications and hormone exposures, and symptoms, mood and sleep. An open track accepts strong proposals outside these areas.

"The best research questions come from people close to the problem," said Meela Ghani, reproductive endocrinology PhD and research scientist at Clair. "We're giving fellows the tools to ask those questions and the support to answer them well."

The fellowship is open to early-career researchers based in the US, including graduate students, postdoctoral researchers, medical residents and fellows, junior faculty and independent researchers. Applications are due January 15, 2027 and are reviewed by Clair's research team and scientific advisors. Decisions will be sent by February 1, 2027.

To encourage collaboration among brands working toward a better future, Clair is inviting other women's health and health tech companies to contribute devices to the program. Clair matches them with funded fellows whose research questions fit, and the fellows run the studies.

Details and applications are at wearclair.com/research/fellowship. Applicants can send questions to Meela Ghani at [email protected].

About Clair

Clair Health makes Clair, a wrist-worn wearable for women that tracks hormonal health continuously. Clair was founded by Stanford graduates Jenny Duan and Abhinav Agarwal, is backed by Khosla Ventures, and launches in the US in Q1 2027. Learn more at wearclair.com.

SOURCE Clair Health